These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36672877)

  • 21. Identification of an EMT-related Gene Signature Predicting Recurrence in Stage II/III Colorectal Cancer: A Retrospective Study in 1780 Patients.
    Ren H; Bösch F; Pretzsch E; Jacob S; Westphalen CB; Walter Holch J; Werner J; Angele MK
    Ann Surg; 2022 Nov; 276(5):897-904. PubMed ID: 35880752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
    Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A molecular signature for the prediction of recurrence in colorectal cancer.
    Wang L; Shen X; Wang Z; Xiao X; Wei P; Wang Q; Ren F; Wang Y; Liu Z; Sheng W; Huang W; Zhou X; Du X
    Mol Cancer; 2015 Feb; 14(1):22. PubMed ID: 25645394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene pair based prognostic signature for colorectal colon cancer.
    Shu P; Wu J; Tong Y; Xu C; Zhang X
    Medicine (Baltimore); 2018 Oct; 97(42):e12788. PubMed ID: 30334969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of an exosomal long non-coding RNAs panel for predicting recurrence risk in patients with colorectal cancer.
    Zhang Y; Liu H; Liu X; Guo Y; Wang Y; Dai Y; Zhuo J; Wu B; Wang H; Zhang X
    Aging (Albany NY); 2020 Apr; 12(7):6067-6088. PubMed ID: 32246818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
    Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
    Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Analysis of Gene Expression Profiles Identifies a
    Chen Z; Chen M; Xue Z; Zhu X
    Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
    [No Abstract]   [Full Text] [Related]  

  • 29. Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers.
    Cai YM; Lu ZQ; Li B; Huang JY; Zhang M; Chen C; Fan LY; Ma QY; He CY; Chen SN; Jiang Y; Li YM; Ning CB; Zhang FW; Wang WZ; Liu YZ; Zhang H; Jin M; Wang XY; Han JX; Xiong Z; Cai M; Huang CQ; Yang XJ; Zhu X; Zhu Y; Miao XP; Zhang SK; Wei YC; Tian JB
    Mil Med Res; 2024 Jun; 11(1):36. PubMed ID: 38863031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
    Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
    Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients.
    Zheng W; Lu Y; Feng X; Yang C; Qiu L; Deng H; Xue Q; Sun K
    Cancer Med; 2021 Sep; 10(17):5998-6009. PubMed ID: 34346563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of genetic signature and TNM staging system for predicting the relapse of locally advanced colorectal cancer.
    Peng J; Wang Z; Chen W; Ding Y; Wang H; Huang H; Huang W; Cai S
    Int J Colorectal Dis; 2010 Nov; 25(11):1277-85. PubMed ID: 20706727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.
    Qian J; Zeng L; Jiang X; Zhang Z; Luo X
    Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer.
    Qu A; Wang Q; Chang Q; Liu J; Yang Y; Zhang X; Zhang Y; Zhang X; Wang H; Zhang Y
    Sci Rep; 2023 Jan; 13(1):1350. PubMed ID: 36693876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.
    Wada Y; Shimada M; Murano T; Takamaru H; Morine Y; Ikemoto T; Saito Y; Balaguer F; Bujanda L; Pellise M; Kato K; Saito Y; Ikematsu H; Goel A
    Gastroenterology; 2021 Jul; 161(1):151-162.e1. PubMed ID: 33819484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
    Ng TH; Sham KWY; Xie CM; Ng SSM; To KF; Tong JHM; Liu WYZ; Zhang L; Chan MTV; Wu WKK; Cheng CHK
    BMC Cancer; 2019 Jul; 19(1):649. PubMed ID: 31266475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
    Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
    Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.